The immune boundaries for stem cell based therapies: problems and prospective solutions
Open Access
- 1 August 2009
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 13 (8a) , 1464-1475
Abstract
Introduction Classification and sources of stem cells Limitations of stem cells Alternatives to overcome the limitations of stem cells Histocompatibility and immune rejection Are ESCs immunogenic or immunoprivileged? Overcoming the need for immune manipulation to avoid rejection Manipulating immune tolerance for stem cell‐based therapies Conclusions Stem cells have fascinated the scientific and clinical communities for over a century. Despite the controversy that surrounds this field, it is clear that stem cells have the potential to revolutionize medicine. However, a number of significant hurdles still stand in the way of the realization of this potential. Chiefly among these are safety concerns, differentiation efficiency and overcoming immune rejection. Here we review current progress made in this field to optimize the safe use of stem cells with particular emphasis on prospective interventions to deal with challenges generated by immune rejection.Keywords
This publication has 183 references indexed in Scilit:
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of toleranceProceedings of the National Academy of Sciences, 2007
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005